Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Leave us alone on healthcare service provision, UK tells EC:

This article was originally published in Clinica

Executive Summary

There are growing concerns about the way in which the proposed EU Services Directive could impact healthcare provision at the national level. In the UK, the British Medical Association is calling for healthcare to be excluded from the scope of the Directive as it fears that there could otherwise be a lowering of standards among doctors in the UK and too much of a business orientation in the provision of healthcare. It is said to have the support of UK government ministers and of governments in other countries too. Although the European Commission claims that it does not intend to tell countries how to run their health services, it is proposing under the Directive that member states would need to justify any proposed changes to their health service rules, and prove them to be "non-discriminatory, necessary or proportional." The BMA is to lobby MEPs on this issue ahead of a public hearing on the proposed Directive, scheduled for November 11 in Brussels.

You may also be interested in...



Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables

Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.

CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings

FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT060085

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel